4-Methylumbelliferone for type 1 diabetes therapy: evidence for β-cell protection via EGFR/PI3K/Akt signaling

Journal of Endocrinological Investigation · Published 2026-06-29 · DOI 10.1007/s40618-026-02964-7

Authors (9)

Shuo Yang, Shanshan Zhu, Xinwen Yu, Wencheng Zhang, Xin Wang, Yuxin Jin, Weiting Wang, Guohong Zhao, Bin Gao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yang, S., Zhu, S., Yu, X., et al. (2026). 4-Methylumbelliferone for type 1 diabetes therapy: evidence for β-cell protection via EGFR/PI3K/Akt signaling. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-026-02964-7

Related articles

• Effect of metreleptin treatment in congenital generalized lipodystrophy: a retrospective analysis from the MENA region · Journal of Endocrinological Investigation · 2026 · Same journal
• An advertising poster of “Aama” a poor french acromegalic giantess sold twice! · Journal of Endocrinological Investigation · 2026 · Same journal
• Determinants of pubertal progression and final height in premature pubarche · Journal of Endocrinological Investigation · 2026 · Same journal
• Glymphatic dysfunction is associated with hyperglycemia-related cortical thinning in patients with type 2 diabetes mellitus · Journal of Endocrinological Investigation · 2026 · Same journal
• Beyond monogenic obesity: the unmet need for anti-obesity pharmacotherapy in rare genetic syndromes · Journal of Endocrinological Investigation · 2026 · Same journal
• Association of C-reactive protein to albumin ratio with progression of CKD and all-cause mortality in diabetic CKD · Journal of Endocrinological Investigation · 2026 · Same journal
• Longitudinal trends in general, central, and visceral adiposity indices among women with endometriosis: a population-based study · Journal of Endocrinological Investigation · 2026 · Same journal
• Oral polychemotherapy to induce remission in newly diagnosed type 2 diabetes: results from a randomized controlled trial · Journal of Endocrinological Investigation · 2026 · Same journal
• Phase angle and triglyceride-glucose index as biomarkers of glycemic control, body composition and cardiovascular risk in adolescents with type 1 diabetes: a cross-sectional study · Journal of Endocrinological Investigation · 2026 · Same journal
• Lactobacillus gasseri alleviates type 2 diabetes via modulation of gut microbiota-host metabolic networks · Journal of Endocrinological Investigation · 2026 · Same journal